Breadcrumb Home Studies Studies Search Filter Research Area AllComplications & ComorbiditiesCureTreatmentTuberculosis Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingTemporarily Closed (Paused) to Accrual and Study Agents/ProductsWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 117 studies. P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed P1100: AERAS 402 DAIDS Number 11801 Research Area Tuberculosis Study Status Concluded P1097: Raltegravir PK Study DAIDS Number 11790 Research Area Treatment Study Status Concluded P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded P1094: Evaluation of the use 3TC DAIDS Number 11769 Research Area Other Study Status Concluded P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Treatment Study Status Closed to Accrual P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Page 12 Next page Next
P1101: Phase I/II Dose-Finding, Safety, Tolerance and Pharmacokinetics Study of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in HIV-infected and TB Co-infected Infants and Children DAIDS Number 11831 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed
P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine DAIDS Number 11796 Research Area Vaccine Study Status Concluded
P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir DAIDS Number 11773 Research Area Treatment Study Status Closed to Accrual
P1092: Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children DAIDS Number 11689 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed
P1090: Safety, Tolerability, Pharmacokinetics and Antiviral Activity of Etravirine DAIDS Number 10850 Research Area Treatment Study Status Participants Off Study and Primary Analysis Completed
P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth DAIDS Number 11670 Research Area Other Study Status Concluded
P1088: H1N1 INFLUENZA VACCINE IN HIV-INFECTED CHILDREN AND ADOLESCENTS DAIDS Number 10840 Research Area Other Study Status Concluded
